{"product_id":"aplar-2024-asia-pacific-league","title":"APLAR 2024 Asia Pacific League of Associations for Rheumatology 26th APALR Congress 2024","description":"\u003cdiv class=\"elementor-element elementor-element-3d496a51 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"3d496a51\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"elementor-widget-container\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3\u003eAPLAR 2024 Asia Pacific League of Associations for Rheumatology 26th APALR Congress 2024\u003c\/h3\u003e\n\u003cbr\u003eThe 26th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2024 will be held from \u003cstrong\u003eAugust 21 to August 25, 2024\u003c\/strong\u003e, in \u003cstrong\u003eSingapore\u003c\/strong\u003e. This congress will feature an array of internationally acclaimed speakers, regional experts, and local talents, offering cutting-edge research, scientific insights, and medical advancements through plenary sessions, concurrent workshops, and poster presentations\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003eThe 26th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2024 is designed for a diverse audience of professionals involved in the field of rheumatology. This includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRheumatologists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eInternists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOrthopaedic surgeons\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eClinical immunologists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePhysiatrists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePhysical and occupational therapists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePaediatricians\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eResearchers from allied disciplines\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe congress aims to provide a platform for these professionals to discuss and deliberate on all aspects of musculoskeletal diseases.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e2023 Japanese CPG.mp4\u003c\/li\u003e\n\u003cli\u003eAbstract session Inflammatory arthritis 2.mp4\u003c\/li\u003e\n\u003cli\u003eAbstract session Myositis Vasculitis Pain.mp4\u003c\/li\u003e\n\u003cli\u003eAdvances in Management of CTD-ILD – Evidence Based Approach for Early Antifibrotic Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eAllied Health Professionals.mp4\u003c\/li\u003e\n\u003cli\u003eAllosteric non-TCR contacting peptide against rheumatoid arthritis from bench to clinical translation.mp4\u003c\/li\u003e\n\u003cli\u003eAPLAR 2024 L Symposium o Early intervention to elevate management goals in SLE.mp4\u003c\/li\u003e\n\u003cli\u003eAPLAR Treatment Recommendation For Psoriatic Arthritic.mp4\u003c\/li\u003e\n\u003cli\u003eAPLAR – EULAR symposium.mp4\u003c\/li\u003e\n\u003cli\u003eArtificial intelligence (Al) in rheumatology.mp4\u003c\/li\u003e\n\u003cli\u003eAsian Countries.mp4\u003c\/li\u003e\n\u003cli\u003eAtherosclerotic vascular disease in SLE.mp4\u003c\/li\u003e\n\u003cli\u003eAuto-inflammatory diseases in children and adults.mp4\u003c\/li\u003e\n\u003cli\u003eAxSpA.mp4\u003c\/li\u003e\n\u003cli\u003eBasic Science Update for RA Recent Insights into the Pathogenic Mechanisms in Disease Throughout Its Natural History.mp4\u003c\/li\u003e\n\u003cli\u003eBiomarkers and Data Analytics Paving the Way for Personalized Treatment with btsDMARDs in Rheumatic Conditions.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Screening in Myositis and Cancer Screening in Myositis How well are we doing.mp4\u003c\/li\u003e\n\u003cli\u003eClinical Efficacy of Seniprutug (BOD-180), anti-TRBV9 therapy for radiographic Axial Spondyloarthritis.mp4\u003c\/li\u003e\n\u003cli\u003eCrystal Arthropathy.mp4\u003c\/li\u003e\n\u003cli\u003eDefining Progression in SSc-ILD.mp4\u003c\/li\u003e\n\u003cli\u003eDouble filtration plasmapheresis reduces type 1 interferon bioavailability and inducing activity in plasma.mp4\u003c\/li\u003e\n\u003cli\u003eEarly intervention in Lupus Nephritis – Asian perspective \u0026amp; challenges.mp4\u003c\/li\u003e\n\u003cli\u003eFertility and sexual health in Rheumatic disease.mp4\u003c\/li\u003e\n\u003cli\u003eFrom clinical to molecular stratification of SSc – is precision medicine a reality.mp4\u003c\/li\u003e\n\u003cli\u003eFrom trials to clinical practice how do today’s therapies help patients achieve their goals.mp4\u003c\/li\u003e\n\u003cli\u003eGRAPPA Workshop @ APLAR 2024.mp4\u003c\/li\u003e\n\u003cli\u003eHealth technologies and patient engagement.mp4\u003c\/li\u003e\n\u003cli\u003eHow to establish APLAR SS registry and CPG.mp4\u003c\/li\u003e\n\u003cli\u003eIJRD metrics 2023.mp4\u003c\/li\u003e\n\u003cli\u003eIMAGING AND GCA-PMR SPECTRUM.mp4\u003c\/li\u003e\n\u003cli\u003eInfections and malignancy.mp4\u003c\/li\u003e\n\u003cli\u003eInfliximab from IV to SC Mainstay Therapy in Rheumatology.mp4\u003c\/li\u003e\n\u003cli\u003eInnovative Therapies in Autoimmune Diseases From Biomarker Insights to Precision Medicine.mp4\u003c\/li\u003e\n\u003cli\u003eMental modes \u0026amp; thinking of Al and Gen Al.mp4\u003c\/li\u003e\n\u003cli\u003eOpening.mp4\u003c\/li\u003e\n\u003cli\u003eOsteoarthritis revisiting regional interests and new therapies.mp4\u003c\/li\u003e\n\u003cli\u003eOsteoporosis debate.mp4\u003c\/li\u003e\n\u003cli\u003ePaediatric Rheumatology- Kidneys, Blood Vessels and Skin.mp4\u003c\/li\u003e\n\u003cli\u003ePlenary session 3 Prof Debashish Danda special lectures.mp4\u003c\/li\u003e\n\u003cli\u003ePre-conference Workshop 1.mp4\u003c\/li\u003e\n\u003cli\u003ePre-conference Workshop 2.mp4\u003c\/li\u003e\n\u003cli\u003ePre-conference Workshop 3.mp4\u003c\/li\u003e\n\u003cli\u003ePre-conference Workshop Musculoskeletal Ultrasound Workshop Ankle and Foot.mp4\u003c\/li\u003e\n\u003cli\u003ePre-conference Workshop Updates and Case Studies in LUPUS.mp4\u003c\/li\u003e\n\u003cli\u003eRaising the bar in RA and AxSpA Challenges and successes of improving lquality of care in Asia-Pacific.mp4\u003c\/li\u003e\n\u003cli\u003eRecent update in paediatric rheumatic diseases.mp4\u003c\/li\u003e\n\u003cli\u003eReproductive Health.mp4\u003c\/li\u003e\n\u003cli\u003eReshaping SLE care Is remission now possible for the many.mp4\u003c\/li\u003e\n\u003cli\u003eRheumatoid Arthritis Challenges \u0026amp; Opportunities.mp4\u003c\/li\u003e\n\u003cli\u003eRheumatoid Arthritis.mp4\u003c\/li\u003e\n\u003cli\u003eRheumatology Imaging It’s values, development and future.mp4\u003c\/li\u003e\n\u003cli\u003eSLE.mp4\u003c\/li\u003e\n\u003cli\u003eSocial factors affecting drug compliance in chronic diseases.mp4\u003c\/li\u003e\n\u003cli\u003eSpA.mp4\u003c\/li\u003e\n\u003cli\u003eSSR-MSR special session.mp4\u003c\/li\u003e\n\u003cli\u003eSymposium Direct Inhibition of lL-6 in Rheumatoid Arthritis Accumulated Experience and Clinical Perspectives.mp4\u003c\/li\u003e\n\u003cli\u003eSynovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis.mp4\u003c\/li\u003e\n\u003cli\u003eThe APLAR Gout Registry Opportunities.mp4\u003c\/li\u003e\n\u003cli\u003eThe Dawn of a New Era in Antiphospholipid Syndrome.mp4\u003c\/li\u003e\n\u003cli\u003eThe Role of Filgotinib in the Management of Rheumatoid Arthritis.mp4\u003c\/li\u003e\n\u003cli\u003eToward better management of vascuflfls.mp4\u003c\/li\u003e\n\u003cli\u003eUnlocking the genetic mysteries of rheumatology a journey into personalised medicine.mp4\u003c\/li\u003e\n\u003cli\u003eValidating the effectiveness of IMACS idiopathic inflammatory myopathy cancer screening guidelines in a Singapore cohort.mp4\u003c\/li\u003e\n\u003cli\u003eVasculitis.mp4\u003c\/li\u003e\n\u003cli\u003eWhat is the next revolution in therapeutics in inflammatory arthritis.mp4\u003c\/li\u003e\n\u003cli\u003eYear in review.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954441293922,"sku":"MED-AMB03606","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/APLAR-2024-Asia-Pacific-League-of-Associations-for-Rheumatology-26th-APALR-Congress-2024.png?v=1779376831","url":"https:\/\/meducourse.com\/products\/aplar-2024-asia-pacific-league","provider":"Meducourse","version":"1.0","type":"link"}